Brokerages expect that Encompass Health Co. (NYSE:EHC) will post $0.78 earnings per share for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Encompass Health’s earnings, with the highest EPS estimate coming in at $0.88 and the lowest estimate coming in at $0.65. Encompass Health posted earnings of $0.93 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 16.1%. The business is scheduled to issue its next quarterly earnings results after the market closes on Wednesday, October 28th.
According to Zacks, analysts expect that Encompass Health will report full year earnings of $2.86 per share for the current financial year, with EPS estimates ranging from $2.35 to $3.21. For the next fiscal year, analysts anticipate that the firm will report earnings of $3.98 per share, with EPS estimates ranging from $3.63 to $4.39. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that cover Encompass Health.
Encompass Health (NYSE:EHC) last issued its earnings results on Monday, July 27th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.08). Encompass Health had a net margin of 6.21% and a return on equity of 16.89%. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion.
Separately, Jefferies Financial Group reduced their target price on Encompass Health from $90.00 to $86.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $91.20.
NYSE:EHC opened at $67.03 on Monday. Encompass Health has a 12-month low of $48.01 and a 12-month high of $83.30. The firm has a market capitalization of $6.67 billion, a price-to-earnings ratio of 23.36, a P/E/G ratio of 5.39 and a beta of 0.80. The stock’s 50 day moving average price is $64.32 and its two-hundred day moving average price is $65.68. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 1.94.
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.28 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.67%. Encompass Health’s dividend payout ratio (DPR) is currently 28.64%.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
See Also: What is the formula for calculating total return?
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.